Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

8 BioPharma Movers That Cannot Be Ignored
24/7 Wall St
Sat, 10/24/15 - 02:28 pm
Tags:
AbbVie, Gilead Sciences, Endo International, Synta Pharmaceuticals, Valeant Pharmaceuticals, Relypsa, Repros Therapeutics, Ocular Therapeutix
FDA's Warning Shakes Up Hep C Landscape
Investopedia
Fri, 10/23/15 - 05:08 pm
Tags:
FDA, warnings, hepatitis C, AbbVie, Gilead Sciences, Harvoni, Viekira Pak
How FDA Warning Could Spell Disaster for AbbVie and Opportunity for Gilead
24/7 Wall St
Fri, 10/23/15 - 11:08 am
Tags:
FDA, Gilead Sciences, AbbVie, hepatitis C, warnings, Viekira Pak, Technivie
FDA issues warning on AbbVie hep C drugs and drugmaker's shares fall 10%
Fierce Pharma
Thu, 10/22/15 - 07:30 pm
Tags:
FDA, hepatitis C, AbbVie, liver damage, Technivie, Viekira Pak
Drug Firms Buy Pricey Vouchers to Speed Products to Market
WSJ Online
Tue, 10/20/15 - 09:52 am
Tags:
review vouchers, United Therapeutics, FDA, AbbVie
In pharma M&A, 2015 trumps red-hot 2014 so far, report says
Fierce Pharma
Mon, 10/19/15 - 09:38 am
Tags:
M&A, Teva Pharmaceutical, Allergan, AbbVie, Pharmacyclics, Perrigo, Mylan Labs
AbbVie's Humira, J&J's Invokana lead September's $231M in pharma TV ad spending
Fierce Pharma Marketing
Wed, 10/14/15 - 11:16 am
Tags:
AbbVie, Humira, JNJ, Invokana, drug ads
Baxalta joins biosim makers eyeing a piece of AbbVie's Humira
Fierce Pharma Marketing
Mon, 10/12/15 - 09:35 am
Tags:
Baxalta, AbbVie, Humira, biosimilars
AbbVie Demonstrates Leadership in Dermatology with 26 Abstracts at the European Academy of Dermatology and Venereology Congress
Yahoo
Mon, 10/5/15 - 09:48 am
Tags:
AbbVie, dermatology
Is Gilead Sciences' Dominance in Hepatitis C Unstoppable?
Motley Fool
Tue, 09/29/15 - 09:04 am
Tags:
Gilead Sciences, hepatitis C, Harvoni, Sovaldi, AbbVie, Viekira Pak, Achillion
Enanta, among Boston's few profitable biotechs, earns another $30M
Bizjournals.com
Mon, 09/28/15 - 08:41 am
Tags:
Enanta, AbbVie, hepatitis C, Viekirax
Can AbbVie Rebound Before Year's End?
Motley Fool
Mon, 09/28/15 - 08:24 am
Tags:
AbbVie
AbbVie dumps Galapagos' arthritis drug and presses on with its own
Fierce Biotech
Fri, 09/25/15 - 10:13 am
Tags:
AbbVie, Galapagos, rheumatoid arthritis, ABT-494, JAK inhibitors
AbbVie has plenty of cost-cutting room if Humira sales hit the skids: analyst
Fierce Pharma
Wed, 09/23/15 - 10:00 pm
Tags:
AbbVie, Humira
AbbVie Not Worried About Humira Biosimilars
Bidness, ETC
Mon, 09/21/15 - 10:54 am
Tags:
AbbVie, Humira, biosimilars, Gilead, Pfizer, Novartis, Amgen
AbbVie Pops On CFO Humira Comments
Barron's
Fri, 09/18/15 - 09:10 pm
Tags:
AbbVie, Humira
AbbVie Stock Update: Humira Growth Set To Increase
Bidness, ETC
Wed, 09/16/15 - 10:22 am
Tags:
AbbVie, Humira
AbbVie edges closer to Imbruvica deal payoff with another FDA filing
Fierce Pharma
Tue, 09/15/15 - 03:16 pm
Tags:
AbbVie, Imbruvica, FDA, JNJ, CLL, chronic lymphocytic leukemia
Why Shares of Halozyme Therapeutics Inc. Plunged 24% in August
Motley Fool
Sun, 09/13/15 - 11:55 am
Tags:
Halozyme, PEGPH20, AbbVie
AbbVie Posts Another Win for Humira
Yahoo/24-7 Wall St
Thu, 09/10/15 - 06:05 pm
Tags:
Humira, AbbVie

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.